Teichmann Sarah A. sold TXG
February 25, 2026 · Form 4 insider transaction
Teichmann Sarah A. sold 7,579 shares of 10x Genomics, Inc. at $19.41 per share, a transaction worth $147.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,579
Price
$19.41
Total value
$147.1K
InsiderTeichmann Sarah A.
RoleDirector
Company10x Genomics, Inc. (TXG)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2026
Filing dateFebruary 27, 2026
Shares owned after26,780
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 26, 2025.